cmsv header img 3

DEVELOPMENT METHODOLOGY

Learn how the CMSV was developed.

The Contraceptive Market Size Visualizer (CMSV) provides two different analyses of the contraceptive market size in the selected countries: a) the subnational estimate of contraceptive utilization and b) the national private sector market size estimation. Each analysis has its specific method, but terms and definitions are consistent.

 

Terminology Definition applied
Current users Women using a modern contraceptive method
Women with an unmet need Women who do not want to become pregnant and who are not currently using any method of contraception
Women with an unmet demand Women who want to avoid pregnancy, are not using any contraceptive method, and say they intend to use contraception in the future or are open to future use
Traditional method users Women who use a traditional method to prevent pregnancy, including withdrawal, periodic abstinence, herbal methods and others
Private sector Includes private hospitals, clinics, doctors, pharmacies, shops/kiosks. Where data is available, non-profit and faith-based organizations are excluded.
Public sector Government hospitals, health centers, clinics, community health workers, and other government health service providers
Injectable contraceptive users Current users of Depot Medroxyprogesterone Acetate Intramuscular (DMPA-IM) and Depot Medroxyprogesterone Acetate Subcutaneous (DMPA-SC)
Other short-term contraceptive methods Condoms, oral contraceptive pills, emergency contraceptive pills
Long-acting reversible methods Intrauterine devices (IUDs), implant
Financial capacity Women living in a household within the third national wealth quintile or above

SUBNATIONAL ESTIMATE OF CONTRACEPTIVE UTILIZAITON

To estimate family planning indicators at the district level, we used a statistical modeling approach that combines information from multiple household surveys conducted over time — including the Demographic and Health Survey (DHS) and Performance Monitoring and Accountability 2020 (PMA) surveys. Because surveys are conducted infrequently and may not cover every district in every round, the model borrows strength across neighboring districts and across years to produce smooth, internally consistent estimates even where direct survey data are sparse. The approach was implemented using the INLA software package in R.²

The model produces an estimated rate for each indicator, which is then converted into an estimated number of people. For example, an estimated mCPR of 40% in a district with 50,000 women of reproductive age yields an estimate of 20,000 modern contraceptive users in that district. Population figures by district were drawn from WorldPop gridded population estimates. To disaggregate total modern contraceptive users into specific methods — such as implants, injectables, pills, and condoms — we used a sequential proportional approach in which each method’s share is estimated one at a time, conditional on the methods already accounted for.³ For injectables, we additionally incorporated monthly public health facility dispensing records (HMIS commodity data) alongside the survey data, allowing facility-level supply information to inform estimates of injectable use at the district level.⁴ Finally, we estimated how users are distributed across public, private, and community sectors, and whether users tend to come from wealthier or poorer households, using individual-level survey responses linked to the district-level estimates.

 

National Private Sector Market Size Estimation

To estimate the national level current and potential market size of the private sector, we calculated the number of clients, volume and value for a full year’s protection for several key contraceptive products for the year 2026 (see figure).

Volume and value estimator figure

Each of the above three group sizes is estimated from WorldPop gridded population estimates, multiplied by family planning use and need proportions estimated from the national level estimates using the subnational market size estimator. Options are available to increase mCPR, private sector utilization, and DMPA-SC use by a specified range.

Estimating the number of clients by type of contraceptive method

  • The number of private sector clients using each modern method can vary, based on changes in mCPR, private sector utilization, and increase in DMPA-SC use.

Estimating volume and value by type of contraceptive method

The total volume for short-term methods is estimated using its respective Couple-Years of Protection (CYP)⁵ factor. The total volume for long-acting reversible methods is estimated to be the same as the number of users who obtained that method from the private sector. Private sector market value was estimated by multiplying the annual units sold for each method by its country-specific average retail price.

 

    References: 

    1. Sully EA, Rosenberg JD, Tignor M, Geddes CE, Dilaverakis Fernandez A, Polis C. Adding It Up 2024: Investing in Sexual and Reproductive Health in Low- and Middle-Income Countries. New York: Guttmacher Institute; 2025. doi:10.1363/2025.300735
    2. Rue H, Martino S, Chopin N. Approximate Bayesian inference for latent Gaussian models by using integrated nested Laplace approximations. Journal of the Royal Statistical Society: Series B. 2009;71(2):319–392.
    3. Lindström J, Kokko T, Enberg K, et al. Bayesian hierarchical modeling of catch-at-age data using a multinomial stick-breaking likelihood. ICES Journal of Marine Science. 2020;77(5):1810–1820.
    4. Bhatt S et al. The effect of malaria control on Plasmodium falciparum in Africa between 2000 and 2015. Nature. 2015;526:207–211
    5. Couple-Years of Protection (CYP) | Global Health | Health Areas | Family Planning and Reproductive Health. U.S. Agency for International Development. Published December 4, 2023. Accessed September 1, 2023. https://www.usaid.gov/global-health/health-areas/family-planning/couple-years-protection-cyp 
    EXPLORE

    CMSV
    HOME

    Book icon

    INTERPRETATION

    The CMSV provides estimates of two different types of contraceptive market size: 1) subnational region and district level users, and 2) national level private sector users, volume, and value of contraceptives.

    READ MORE
    Gear icon

    METHODOLOGY

    Using nationally representative surveys, routine health service data, and high-resolution population data, the subnational market size estimation serves to illustrate the distribution of contraceptive users and those with contraceptive needs.

    READ MORE
    Question mark icon

    FREQUENTLY ASKED QUESTIONS

    Have a question? See if it has an answer in our FAQ section.

    READ MORE
    Map icon

    EXAMPLE USE CASES

    How can policy makers, private sector actors, donors, non-governmental organizations, advocates, and researchers use the CMSV?

    READ MORE
    LEARN MORE

    Contact us to learn how Metrics for Management can help you use targeted, accurate, and measurable data to expand and improve your services.

    GET IN TOUCH

    AIMS Partners

    The CMSV is a product of the Advancing Injectable Markets for Sustainability (AIMS) project which is led by PATH in partnership with the Africa Resource Centre, Health Systems Insight, Metrics for Management, and Solina Centre for International Development and Research. Dedicated to improving women's choice and access to injectable contraception, AIMS is creating a sustainable market for DMPA-SC and self-injection, ensuring balanced supply and demand, with robust public- and private-sector access to contraceptive injectables for women living in low- and middle-income countries. For more www.FPoptions.org | FPoptions@path.org.

    PATH Africa Resource Centre Health Systems Insight Metrics for Management SCIDaR

    Metrics for Management © 2026 | in Bluesky